Aruvant Announces Data Presentation on Lead Program ARU-1801 at European Hematology Association (EHA) 2021 Virtual Congress
/PRNewswire/ -- Aruvant Sciences ("Aruvant"), a private company focused on developing gene therapies for rare diseases, today announced the selection of an...
Instagram Aruvant Aruvant Sciences European Hematology Association Virtual Congress Will Chou Towards Patient Specific Dosing
Source: prnewswire.com